Add BrightSurf on Google Email

Researchers find 2 new methods to determine ALK status

Researchers have developed two new methodologies to determine ALK status in non–small-cell lung cancer (NSCLC) patients. The first method improves IHC assay sensitivity using a novel hapten and tyramide amplification, detecting low levels of ALK protein expression. The second method combines brightfield IHC with in situ hybridization f...

SourceInternational Association for the Study of Lung Cancer·JournalJournal of Thoracic Oncology·DateJul 1, 2013

Grant to further childhood sarcoma therapeutic research

Researchers will study pediatric sarcomas, a rare and aggressive form of cancer affecting 11% of all childhood cancers, with the goal of developing new therapies. The project aims to improve outcomes for children with advanced or metastatic disease, who have limited success with current treatments.

SourceNationwide Children's Hospital·DateJun 26, 2013

Immunohistochemistry effectively detects ALK rearrangement

Researchers evaluate immunohistochemistry for detecting ALK rearrangement in lung adenocarcinoma, finding it a reliable and cost-effective method. The study suggests that IHC can effectively detect ALK rearrangement and identify suitable candidates for targeted therapy.

SourceInternational Association for the Study of Lung Cancer·JournalJournal of Thoracic Oncology·DateJun 25, 2013
Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

Study shows heart failure survivors at greater risk for cancer

A recent study published in the Journal of the American College of Cardiology found that heart failure patients are more likely to develop cancer, with a significant increase in mortality rates. The study suggests that side effects of cardiovascular treatments and inflammation may be contributing factors.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateJun 25, 2013

JCI early table of contents for June 24, 2013

A study finds a link between prenatal ICP and postnatal obesity in offspring, while another investigation reveals genetic changes in preeclampsia and brain inflammation caused by chronic cannabis use. These findings may have implications for understanding and treating metabolic diseases and pregnancy complications.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 24, 2013

Chlamydia promotes gene mutations

Researchers at Max Planck Institute discover Chlamydia promotes gene mutations, impairing DNA damage response and leading to uncontrolled cell growth. The infection can cause chronic damage, increasing risk of cervical and ovarian cancer.

SourceMax-Planck-Gesellschaft·JournalCell Host & Microbe·DateJun 20, 2013

Hormonal therapy for transsexualism safe and effective

A multicenter European study found that short-term hormonal therapy for transsexualism is effective and safe, with few side effects. The treatment, which involves large doses of male or female sex hormones, was shown to be effective in changing the external characteristics of trans individuals.

SourceThe Endocrine Society·DateJun 18, 2013
Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.

Spanish researchers writing in cell describe the 9 hallmarks of aging

Researchers from Spain and the US have identified nine molecular hallmarks of aging, including genomic instability, telomere shortening, and epigenetic alterations. By understanding these hallmarks, they hope to develop treatments that can combat cancer and other diseases linked to aging.

SourceCentro Nacional de Investigaciones Oncológicas (CNIO)·JournalCell·DateJun 6, 2013
Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

U of M researchers find novel gene correction model for epidermolysis bullosa

Researchers at the University of Minnesota have discovered a way to correct genetic defects in skin cells of patients with epidermolysis bullosa. They used engineered transcription activator-like effector nucleases to target and fix mutation-causing genes, resulting in the production of missing proteins in living skin models.

SourceUniversity of Minnesota Academic Health Center·JournalMolecular Therapy·DateJun 6, 2013

Big multiple sclerosis breakthrough

A phase 1 clinical trial shows a new treatment safely reduces immune system reactivity to myelin in multiple sclerosis patients by 50-75%. The therapy, which uses specially processed white blood cells, preserves the function of the normal immune system. Researchers hope to launch a phase 2 trial to prevent MS progression.

SourceNorthwestern University·JournalScience Translational Medicine·DateJun 5, 2013

Tools for better understanding breast cancer stem cells

Scientists have created a model to study breast cancer biology, confirming that primary tissue from patients behaves similarly to those derived from long-term cultured cell lines. This breakthrough advances the development of targeted therapies for advanced cancer treatments.

SourceGriffith University·JournalPLOS ONE·DateJun 4, 2013
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

New strategy for defeating neuroblastoma

Researchers at Karolinska Institutet have discovered a promising strategy for defeating neuroblastoma by targeting the MYCN protein. The approach involves inhibiting the MYC gene, which leads to the accumulation of fat droplets in cancer cells and ultimately causes cell death or development into harmless neurons.

SourceKarolinska Institutet·JournalProceedings of the National Academy of Sciences·DateJun 3, 2013

Cytomegalovirus might speed brain-cancer growth

Researchers found that cytomegalovirus (CMV) can speed the progression of glioblastoma, a deadly form of brain cancer, when particular genes are shut off. CMV was found to stimulate tumor-cell proliferation by activating a biochemical cell pathway called STAT3.

SourceOhio State University Wexner Medical Center·JournalCancer Research·DateJun 1, 2013

Beaumont study: Nerve stimulation helps with overactive bladder

A three-year study published in The Journal of Urology finds that tibial nerve stimulation significantly improves symptoms of overactive bladder. Participants experienced a nearly 30% decrease in daytime trips to the bathroom and almost 40% fewer nighttime trips.

SourceBeaumont Health System·JournalThe Journal of Urology·DateMay 30, 2013
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

Researchers discover new weapon in fight against cervical cancer

Scientists at the University of Leeds have discovered a molecule that targets and destroys a key protein associated with the development of cervical and other cancers. The RNA aptamer latches onto the carcinogenic protein, significantly reducing its presence in cells in laboratory-derived cervical cancer cells.

SourceUniversity of Leeds·JournalPLOS ONE·DateMay 30, 2013

New fluorescent tools for cancer diagnosis

Researchers at Rockefeller University have developed a multicolor fluorescence labeling method to visualize miRNAs in tissue sections, enabling the identification of tumor-specific miRNAs and distinguishing between different tumor types. This technology shows promise as a molecular diagnostic tool for clinical settings.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 24, 2013
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Cancer survivors battle with the blues

Depressive symptoms observed in cancer survivors between one and ten years after diagnosis increase the risk of premature death. Cancer survivors with depression are twice as likely to have died early compared to those without depression.

SourceSpringer·JournalJournal of Cancer Survivorship·DateMay 16, 2013
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

Agent Orange exposure linked to life-threatening prostate cancer

A new analysis found a significant link between Agent Orange exposure and high-grade prostate cancer among US Veterans. Exposure to the herbicide was associated with a 52% increase in overall risk of prostate cancer detection by biopsy, as well as a 75% increase in risk of high-grade prostate cancer.

SourceWiley·JournalCancer·DateMay 13, 2013

Study identifies possible new acute leukemia marker, treatment target

A new study identifies microRNA-155 as a potential treatment target and prognostic marker for patients with cytogenetically normal acute myeloid leukemia. High levels of miR-155 expression are associated with poorer patient outcomes, including lower complete remission rates and shorter overall survival.

SourceOhio State University Wexner Medical Center·JournalJournal of Clinical Oncology·DateMay 13, 2013
Kestrel 3000 Pocket Weather Meter

Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.

New prostate cancer test improves risk assessment

A new genomic test helps identify low-risk men suitable for active surveillance, sparing them from unnecessary treatment. The test provides statistically significant and clinically meaningful prognostic information, aiding in determining which men are best suited for active surveillance.

SourceUniversity of California - San Francisco·DateMay 8, 2013

BIDMC's Dennis P. Wall honored for autism research

BIDMC's Dennis P. Wall has developed a new method to diagnose autism in young children quickly and accurately, enabling rapid online assessments. This approach has shown promise in clinical environments, with the potential to improve early diagnosis and treatment outcomes.

SourceBeth Israel Deaconess Medical Center·DateMay 8, 2013

Minimal dose CT superior to chest X-ray for detection of recurrent lung cancer

A new study shows that minimal dose computed tomography (MnDCT) is more sensitive than conventional chest X-rays in detecting new or recurrent lung cancer, while delivering a similar amount of radiation. The study found that MnDCT detected 94% of recurrent cancers compared to 21%, allowing for earlier treatment and longer survival rates.

SourceAmerican Association for Thoracic Surgery·DateMay 6, 2013
Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

Study examines spiritual support for patients with advanced cancer

A study found that high spiritual support from religious communities is associated with reduced aggressive treatment in patients with advanced cancer. Patients receiving spiritual support from the medical team had higher rates of hospice use, fewer aggressive treatments, and fewer ICU deaths.

SourceJAMA Network·JournalJAMA Internal Medicine·DateMay 6, 2013

Cancer treatment could target inflammation in CVD

Researchers found that PRRT decreases inflammation in atherosclerotic plaques, as measured by DOTATATE PET/CT, suggesting potential therapeutic benefits for cardiovascular disease. The study suggests that this treatment may reduce the occurrence of heart attacks by lowering inflammation levels.

SourceEuropean Society of Cardiology·DateMay 4, 2013

Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer

A new analysis compared five different scores to predict late recurrence in estrogen-receptor positive breast cancer patients. The Clinical Treatment Score was found to be the best predictor of late recurrence, while the PAM50 Risk of Recurrence and Breast Cancer Index scores added significant prognostic value.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateMay 2, 2013

Gene expression test distinguishes between breast cancer patients at high and low risk of late recurrence

A gene expression test measures 58 genes in oestrogen receptor-positive breast cancers to differentiate between patients with high and low risk of late recurrence. The test provided significant prognostic information for late distant-relapse-free survival, with better individual risk prediction for women.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateMay 2, 2013
Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

DCIS Score quantifies risk of IBE

A new tool, the DCIS Score, complements traditional factors to predict IBE risk in women with DCIS treated without radiation. The score helps guide personalized treatment decisions.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateMay 2, 2013

Searching for therapeutic synergy in primary effusion lymphoma

Researchers found that a Bortezomib/Vorinostat combination therapy reactivated virus-induced cell lysis and induced PEL cell death, increasing the lifespan of mice with PEL tumors. This treatment combination could potentially be beneficial for immunocompromised patients with KSHV-associated malignancies.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 1, 2013

JCI early table of contents for May 1, 2013

Researchers identified a specific pattern of DNA modifications dependent on HPV presence that correlates with improved survival in patients with OPSCC. A new combination therapy for PEL was found to reactivate virus-induced cell lysis and induce cancer cell death, increasing mouse lifespan.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 1, 2013
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

Discovery helps explain how children develop rare, fatal disease

Researchers at the University of Missouri have found that the ATP7A gene is essential for copper absorption, leading to a better understanding of Menkes disease. The study used laboratory mice and discovered that the gene's absence can lead to copper deficiency symptoms similar to those seen in children with the disease.

SourceUniversity of Missouri-Columbia·DateApr 30, 2013

Food dye could provide 'blueprint' for treatment of Panx1-related diseases

Researchers discovered BB FCF as a selective inhibitor of Panx1, a protein involved in inflammation and cell death. The study suggests that BB FCF could aid in the development of pharmacological tools to inhibit Panx1, potentially treating conditions such as Crohn's disease and AIDS.

SourceRockefeller University Press·JournalJournal of General Physiology·DateApr 29, 2013

Team finds markers related to ovarian cancer survival and recurrence

The team identified 21 microRNAs associated with ovarian cancer survival and 838 target genes linked to its progression. The findings suggest a network-based approach can predict cancer survival and recurrence more accurately than individual biomarkers.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalPLOS ONE·DateApr 29, 2013
Sky-Watcher EQ6-R Pro Equatorial Mount

Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.

Chernobyl follow-up study finds high survival rate among young thyroid cancer patients

A recent study found that nearly all children and teenagers with differentiated thyroid cancer due to radiation have responded favorably to treatment, with 64% in complete remission. The findings suggest victims of recent nuclear accidents like Fukushima may face a lower risk of developing advanced-stage thyroid cancer.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateApr 24, 2013

Using microbubbles to improve cancer therapy

Researchers developed phase shift nanoemulsions that produce tiny microbubbles, which accumulate in tumors and amplify the effects of ultrasound. This reduces treatment time and power needed to destroy tumor tissue by over half, showing promise for improving cancer therapy.

SourceBMC (BioMed Central)·JournalJournal of Therapeutic Ultrasound·DateApr 24, 2013

Majority of children readmitted to hospital following stem cell transplant

A study by Dana-Farber Cancer Institute found that nearly two-thirds of children receiving stem cell transplants were readmitted to the hospital within six months for treatment of unexplained fevers, infections or other problems. Children who received donor cells were twice as likely to be readmitted compared to those with their own st...

SourceDana-Farber Cancer Institute·DateApr 24, 2013
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

New ablation technique holds promise for liver cancer patients

A new minimally invasive tumor ablation technique called irreversible electroporation (IRE) has shown promising results in treating liver cancer patients who cannot undergo surgery or thermal ablation. The study found that IRE successfully destroyed tumor tissue in 70% of patients, with two major complications reported but neither life...

SourceAmerican Roentgen Ray Society·DateApr 18, 2013

Survived cancer? Now look out for cardiovascular risks

A new study reveals that cancer survivors are at higher risk of cardiovascular disease due to shared risk factors like smoking and obesity. The research emphasizes the importance of assessing cardiovascular risk as part of a comprehensive survivorship care plan.

SourceAtrium Health Wake Forest Baptist·JournalJournal of Cancer Survivorship·DateApr 16, 2013
Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

Is medical therapy a better and safer choice than angioplasty

A new study suggests that medical therapy is a viable alternative to angioplasty in treating stable coronary artery disease, reducing the risk of complications and hospitalizations. The study proposes a targeted approach to shared decision-making, considering treatment options, risks, and outcomes for patients.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalPopulation Health Management·DateApr 9, 2013

American College of Physicians releases new prostate cancer screening guidance statement

The American College of Physicians suggests that men between 50-69 discuss potential benefits and harms of the PSA test before screening. The risks include problems interpreting test results, biopsy complications, and treatment side effects. ACP recommends against testing in men younger than 50 or older than 69 with low life expectancy.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateApr 8, 2013
Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.

Counting copy numbers characterizes prostate cancer

Researchers have developed a non-invasive test for metastatic prostate cancer using whole-genome analysis of plasma DNA, which identifies abnormal copy numbers of specific sequences. This breakthrough could aid personalized therapy and target treatment for castration-resistant prostate cancer.

SourceBMC (BioMed Central)·JournalGenome Medicine·DateApr 4, 2013

Prostate cancer treatment study changing the way doctors practice

A study published in the New England Journal of Medicine recommends continuous hormone therapy for metastatic prostate cancer, extending lives by months to years. Continuous therapy offers a better alternative to intermittent therapy with fewer side effects.

SourceUniversity of Texas Health Science Center at San Antonio·JournalNew England Journal of Medicine·DateApr 3, 2013